The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis

Annals of the New York Academy of Sciences

Volumn 1283, Issue 1, 2013, Pages 22-29

  Weiner, January ^a   Maertzdorf, Jeroen ^a   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

Biomarkers; Transcriptomics; Tuberculosis; Vaccination

Indexed keywords

SUPPRESSOR OF CYTOKINE SIGNALING;

ARTICLE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HIGH THROUGHPUT SCREENING; HUMAN; MULTIPLEX POLYMERASE CHAIN REACTION; POINT OF CARE TESTING; PREDICTION; TRANSCRIPTOMICS; TUBERCULOSIS;

EID: 84876796413     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06802.x     Document Type: Article

References (50)

1. World Health Organization. Global tuberculosis control 2011. 2011. World Health Organization. Geneva. Available at www.who.int/tb/publications/global_report/2011/en/index.html.
2. Kaufmann, S.H. 2011. Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infect. Dis. 11: 633-640.
3. Raviglione, M., B. Marais, K. Floyd, et al. 2012. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 379: 1902-1913.
4. Maertzdorf, J., I.J. Weiner & S.H. Kaufmann . 2012. Enabling biomarkers for tuberculosis control. Int. J Tuberc. Lung Dis. 16: 1140-1148.
5. Boehme, C.C., M.P. Nicol, P. Nabeta, et al. 2011. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495-1505.
6. Davies, P.D. & M. Pai . 2008. The diagnosis and misdiagnosis of tuberculosis. Int. J. Tuberc. Lung Dis. 12: 1226-1234.
7. Philips, J.A. & J.D. Ernst . 2012. Tuberculosis pathogenesis and immunity. Annu. Rev. Pathol. 7: 353-384.
8. Pai, M., K. Gokhale, R. Joshi, et al. 2005. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 293: 2746-2755.
9. Wallis, R.S., M. Pai, D. Menzies, et al. 2010. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375: 1920-1937.
10. Parida, S.K. & S.H. Kaufmann . 2010. The quest for biomarkers in tuberculosis. Drug Discov. Today 15: 148-157.
11. Mistry, R., J.M. Cliff, C.L. Clayton, et al. 2007. Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J. Infect. Dis. 195: 357-365.
12. Jacobsen, M., D. Repsilber, A. Gutschmidt, et al. 2007. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J. Mol. Med. 85: 613-621.
13. Jacobsen, M., J. Mattow, D. Repsilber & S.H. Kaufmann . 2008. Novel strategies to identify biomarkers in tuberculosis. Biol. Chem. 389: 487-495.
14. Berry, M.P., C.M. Graham, F.W. McNab, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
15. Maertzdorf, J., M. Ota, D. Repsilber, et al. 2011. Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One 6: e26938.
16. Maertzdorf, J., D. Repsilber, S.K. Parida, et al. 2011. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun. 12: 15-22.
17. Lesho, E., F.J. Forestiero, M.H. Hirata, et al. 2011. Transcriptional responses of host peripheral blood cells to tuberculosis infection. Tuberculosis 91: 390-399.
18. Jacobsen, M., D. Repsilber, K. Kleinsteuber, et al. 2011. Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients. Clin. Microbiol. Infect. 17: 1323-1331.
19. Walzl, G., K. Ronacher, W. Hanekom, et al. 2011. Immunological biomarkers of tuberculosis. Nat. Rev. Immunol. 11: 343-354.
20. John, S.H., J. Kenneth & A.S. Gandhe . 2012. Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies. Biomarkers 17: 1-8.
21. Djebali, S., C.A. Davis, A. Merkel, et al. 2012. Landscape of transcription in human cells. Nature 489: 101-108.
22. O'Connell, R.M., D.S. Rao & D. Baltimore . 2012. microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30: 295-312.
23. Moazed, D. 2009. Small RNAs in transcriptional gene silencing and genome defence. Nature 457: 413-420.
24. Hassan, T., P.J. McKiernan, N.G. McElvaney, et al. 2012. Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases. Expert Rev. Anti. Infect. Ther. 10: 359-368.
25. Wery, M., M. Kwapisz & A. Morillon . 2011. Noncoding RNAs in gene regulation. Wiley Interdiscip. Rev. Syst. Biol. Med. 3: 728-738.
26. Wang, C., S. Yang, G. Sun, et al. 2011. Comparative miRNA expression profiles in individuals with latent and active tuberculosis. PLoS One 6: e25832.
27. Fu, Y., Z. Yi, X. Wu, et al. 2011. Circulating microRNAs in patients with active pulmonary tuberculosis. J. Clin. Microbiol. 49: 4246-4251.
28. Liu, Y., X. Wang, J. Jiang, et al. 2011. Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. Mol. Immunol. 48: 1084-1090.
29. Wu, J., C. Lu, N. Diao, et al. 2012. Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study. Hum. Immunol. 73: 31-37.
30. Dorhoi, A., M. Iannaccone, M. Farinacci, et al. The microRNA miR-223 constrains lethal inflammation during Mycobacterium tuberculosis infection. Submitted for publication.
31. Kaddurah-Daouk, R., B.S. Kristal & R.M. Weinshilboum . 2008. Metabolomics: a global biochemical approach to drug response and disease. Annu. Rev. Pharmacol. Toxicol. 48: 653-683.
32. Griffin, J.L. & J.P. Shockcor . 2004. Metabolic profiles of cancer cells. Nat. Rev. Cancer 4: 551-561.
33. Sabatine, M.S., E. Liu, D.A. Morrow, et al. 2005. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112: 3868-3875.
34. Wang, T.J., M.G. Larson, R.S. Vasan, et al. 2011. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17: 448-453.
35. Jeon, C.Y. & M.B. Murray . 2008. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 5: e152.
36. Galon, J., D. Franchimont, N. Hiroi, et al. 2002. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16: 61-71.
37. Saric, J. 2010. Interactions between immunity and metabolism-contributions from the metabolic profiling of parasite-rodent models. Parasitology 137: 1451-1466.
38. Hasko, G., D.G. Kuhel, Z.H. Nemeth, et al. 2000. Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J. Immunol. 164: 1013-1019.
39. Slupsky, C.M., K.N. Rankin, H. Fu, et al. 2009. Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. J. Proteome Res. 8: 5550-5558.
40. Laiakis, E.C., G.A. Morris, A.J. Fornace & S.R. Howie . 2010. Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One 5(9): pii: e12655.
41. Shin, J.H., J.Y. Yang, B.Y. Jeon, et al. 2011. H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J. Proteome Res. 10: 2238-2247.
42. Somashekar, B.S., A.G. Amin, C.D. Rithner, et al. 2011. Metabolic profiling of lung granuloma in Mycobacterium tuberculosis infected guinea pigs: ex vivo 1H magic angle spinning NMR studies. J. Proteome Res. 10: 4186-4195.
43. Weiner, J., III, S.K. Parida, J. Maertzdorf, et al. 2012. Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PLoS One 7: e40221.
44. de Jong, W.H., R. Smit, S.J. Bakker, et al. 2009. Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC-tandem mass spectrometry. J Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 603-609.
45. Maertzdorf, J., J. Weiner, III, H.J. Mollenkopf, et al. 2012. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc. Natl. Acad. Sci. USA 109: 7853-7858.
46. Phillips, M., V. Basa-Dalay, G. Bothamley, et al. 2010. Breath biomarkers of active pulmonary tuberculosis. Tuberculosis 90: 145-151.
47. Sandhu, G., F. Battaglia, B.K. Ely, et al. 2012. Discriminating active from latent tuberculosis in patients presenting to community clinics. PLoS One 7: e38080.
48. Koth, L.L., O.D. Solberg, J.C. Peng, et al. 2011. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am. J. Respir. Crit. Care Med. 184: 1153-1163.
49. Blanchet, L., A. Smolinska, A. Attali, et al. 2011. Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis. BMC. Bioinform. 12: 254.
50. Ottenhoff, T.H., J.J. Ellner & S.H. Kaufmann . 2012. Ten challenges for TB biomarkers. Tuberculosis 92(Suppl 1): S17-S20.